Table of Contents

2019-2024 Global Biosimilar Monoclonal Antibodies Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Monoclonal Antibodies Consumption 2014-2024
2.1.2 Biosimilar Monoclonal Antibodies Consumption CAGR by Region
2.2 Biosimilar Monoclonal Antibodies Segment by Type
2.2.1 Infliximab
2.2.2 Rituximab
2.2.3 Trastuzumab
2.2.4 Adalimumab
2.2.5 Other
2.3 Biosimilar Monoclonal Antibodies Consumption by Type
2.3.1 Global Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2014-2019)
2.3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2014-2019)
2.3.3 Global Biosimilar Monoclonal Antibodies Sale Price by Type (2014-2019)
2.4 Biosimilar Monoclonal Antibodies Segment by Application
2.4.1 Oncology
2.4.2 Autoimmune Disease
2.4.3 Other
2.5 Biosimilar Monoclonal Antibodies Consumption by Application
2.5.1 Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2014-2019)
2.5.2 Global Biosimilar Monoclonal Antibodies Value and Market Share by Application (2014-2019)
2.5.3 Global Biosimilar Monoclonal Antibodies Sale Price by Application (2014-2019)

3 Global Biosimilar Monoclonal Antibodies by Players
3.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Players
3.1.1 Global Biosimilar Monoclonal Antibodies Sales by Players (2017-2019)
3.1.2 Global Biosimilar Monoclonal Antibodies Sales Market Share by Players (2017-2019)
3.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Players
3.2.1 Global Biosimilar Monoclonal Antibodies Revenue by Players (2017-2019)
3.2.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Players (2017-2019)
3.3 Global Biosimilar Monoclonal Antibodies Sale Price by Players
3.4 Global Biosimilar Monoclonal Antibodies Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Biosimilar Monoclonal Antibodies Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Biosimilar Monoclonal Antibodies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Biosimilar Monoclonal Antibodies by Regions
4.1 Biosimilar Monoclonal Antibodies by Regions
4.1.1 Global Biosimilar Monoclonal Antibodies Consumption by Regions
4.1.2 Global Biosimilar Monoclonal Antibodies Value by Regions
4.2 Americas Biosimilar Monoclonal Antibodies Consumption Growth
4.3 APAC Biosimilar Monoclonal Antibodies Consumption Growth
4.4 Europe Biosimilar Monoclonal Antibodies Consumption Growth
4.5 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Growth

5 Americas
5.1 Americas Biosimilar Monoclonal Antibodies Consumption by Countries
5.1.1 Americas Biosimilar Monoclonal Antibodies Consumption by Countries (2014-2019)
5.1.2 Americas Biosimilar Monoclonal Antibodies Value by Countries (2014-2019)
5.2 Americas Biosimilar Monoclonal Antibodies Consumption by Type
5.3 Americas Biosimilar Monoclonal Antibodies Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Biosimilar Monoclonal Antibodies Consumption by Countries
6.1.1 APAC Biosimilar Monoclonal Antibodies Consumption by Countries (2014-2019)
6.1.2 APAC Biosimilar Monoclonal Antibodies Value by Countries (2014-2019)
6.2 APAC Biosimilar Monoclonal Antibodies Consumption by Type
6.3 APAC Biosimilar Monoclonal Antibodies Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Biosimilar Monoclonal Antibodies by Countries
7.1.1 Europe Biosimilar Monoclonal Antibodies Consumption by Countries (2014-2019)
7.1.2 Europe Biosimilar Monoclonal Antibodies Value by Countries (2014-2019)
7.2 Europe Biosimilar Monoclonal Antibodies Consumption by Type
7.3 Europe Biosimilar Monoclonal Antibodies Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Biosimilar Monoclonal Antibodies by Countries
8.1.1 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Biosimilar Monoclonal Antibodies Value by Countries (2014-2019)
8.2 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Type
8.3 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biosimilar Monoclonal Antibodies Distributors
10.3 Biosimilar Monoclonal Antibodies Customer

11 Global Biosimilar Monoclonal Antibodies Market Forecast
11.1 Global Biosimilar Monoclonal Antibodies Consumption Forecast (2019-2024)
11.2 Global Biosimilar Monoclonal Antibodies Forecast by Regions
11.2.1 Global Biosimilar Monoclonal Antibodies Forecast by Regions (2019-2024)
11.2.2 Global Biosimilar Monoclonal Antibodies Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biosimilar Monoclonal Antibodies Forecast by Type
11.8 Global Biosimilar Monoclonal Antibodies Forecast by Application

12 Key Players Analysis
12.1 Celltrion
12.1.1 Company Details
12.1.2 Biosimilar Monoclonal Antibodies Product Offered
12.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Celltrion News
12.2 Pfizer (Hospira)
12.2.1 Company Details
12.2.2 Biosimilar Monoclonal Antibodies Product Offered
12.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Pfizer (Hospira) News
12.3 3SBIO
12.3.1 Company Details
12.3.2 Biosimilar Monoclonal Antibodies Product Offered
12.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 3SBIO News
12.4 Novartis (Sandoz)
12.4.1 Company Details
12.4.2 Biosimilar Monoclonal Antibodies Product Offered
12.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Novartis (Sandoz) News
12.5 Dr Reddy?s
12.5.1 Company Details
12.5.2 Biosimilar Monoclonal Antibodies Product Offered
12.5.3 Dr Reddy?s Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Dr Reddy?s News
12.6 Celgen Biopharma
12.6.1 Company Details
12.6.2 Biosimilar Monoclonal Antibodies Product Offered
12.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Celgen Biopharma News
12.7 Cadila Healthcare
12.7.1 Company Details
12.7.2 Biosimilar Monoclonal Antibodies Product Offered
12.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Cadila Healthcare News
12.8 Hisun Pharma
12.8.1 Company Details
12.8.2 Biosimilar Monoclonal Antibodies Product Offered
12.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Hisun Pharma News
12.9 Torrent Pharmaceuticals
12.9.1 Company Details
12.9.2 Biosimilar Monoclonal Antibodies Product Offered
12.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Torrent Pharmaceuticals News

13 Research Findings and Conclusion